• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.

作者信息

Martinez-Naharro Ana, Abdel-Gadir Amna, Treibel Thomas A, Zumbo Giulia, Knight Daniel S, Rosmini Stefania, Lane Thirusha, Mahmood Shameem, Sachchithanantham Sajitha, Whelan Carol J, Lachmann Helen J, Wechalekar Ashutosh D, Kellman Peter, Gillmore Julian D, Moon James C, Hawkins Philip N, Fontana Marianna

出版信息

JACC Cardiovasc Imaging. 2018 Jan;11(1):152-154. doi: 10.1016/j.jcmg.2017.02.012. Epub 2017 Apr 12.

DOI:10.1016/j.jcmg.2017.02.012
PMID:28412427
Abstract
摘要

相似文献

1
CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.化疗后经心脏磁共振成像（CMR）验证的心脏轻链型淀粉样变的消退
JACC Cardiovasc Imaging. 2018 Jan;11(1):152-154. doi: 10.1016/j.jcmg.2017.02.012. Epub 2017 Apr 12.
2
Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis.连续进行天然T1映射以监测轻链淀粉样变性患者心脏对治疗的反应。
Circ Cardiovasc Imaging. 2016 Oct;9(10). doi: 10.1161/CIRCIMAGING.116.004770.
3
Light-Chain Cardiac Amyloidosis: Cardiac Magnetic Resonance for Assessing Response to Chemotherapy.轻链心脏淀粉样变：评估化疗反应的心脏磁共振成像。
Korean J Radiol. 2024 May;25(5):426-437. doi: 10.3348/kjr.2023.0985.
4
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?系统性轻链淀粉样变中心脏淀粉样变负荷的改善定量：重新定义早期疾病？
JACC Cardiovasc Imaging. 2020 Jun;13(6):1325-1336. doi: 10.1016/j.jcmg.2020.02.025. Epub 2020 May 13.
5
Chest Pain and a Very Abnormal Stress Echocardiogram.胸痛与一份极异常的负荷超声心动图检查结果
Circulation. 2018 Oct 23;138(17):1899-1903. doi: 10.1161/CIRCULATIONAHA.118.033885.
6
Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.心脏磁共振和超声心动图检查发现的淀粉样变性所致的心脏结构和功能改变及其预后价值。
JACC Cardiovasc Imaging. 2019 May;12(5):823-833. doi: 10.1016/j.jcmg.2018.02.016. Epub 2018 Apr 18.
7
The prognostic value of CMR diastolic parameters in patients with cardiac light-chain amyloidosis: a retrospective analysis.心脏轻链淀粉样变患者中CMR舒张参数的预后价值：一项回顾性分析。
Int J Cardiovasc Imaging. 2025 Mar;41(3):579-589. doi: 10.1007/s10554-025-03347-4. Epub 2025 Feb 14.
8
Finally Getting to the Heart of the Matter: Imaging Multiorgan Treatment Response in AL Amyloidosis.
JACC Cardiovasc Imaging. 2023 Aug;16(8):1053-1055. doi: 10.1016/j.jcmg.2023.03.022. Epub 2023 May 31.
9
Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.转甲状腺素蛋白与免疫球蛋白轻链淀粉样变患者的心房功能和几何结构差异：一项心脏磁共振研究。
Sci Rep. 2022 Jan 7;12(1):140. doi: 10.1038/s41598-021-03359-9.
10
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy.成功治疗后 1 年以上的轻链心脏淀粉样变性的心肌成分。
JACC Cardiovasc Imaging. 2022 Apr;15(4):594-603. doi: 10.1016/j.jcmg.2021.09.032. Epub 2021 Dec 15.

引用本文的文献

1
Prognostic value of CMR parametric mapping in cardiac amyloidosis: an updated systematic review and meta-analysis.心脏磁共振成像参数映射在心脏淀粉样变性中的预后价值：一项更新的系统评价和荟萃分析。
Open Heart. 2025 Aug 14;12(2):e003551. doi: 10.1136/openhrt-2025-003551.
2
Emerging Insights into Granulomatous and Amyloidogenic Cardiomyopathies.对肉芽肿性和淀粉样变性心肌病的新见解
J Clin Med. 2025 Jun 13;14(12):4208. doi: 10.3390/jcm14124208.
3
Cardiac Magnetic Resonance Imaging in the Evaluation and Prognosis of Infiltrative Cardiomyopathies.
心脏磁共振成像在浸润性心肌病评估与预后中的应用
J Cardiovasc Dev Dis. 2025 Apr 12;12(4):154. doi: 10.3390/jcdd12040154.
4
Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging.转甲状腺素蛋白淀粉样心肌病：多模态成像的当前诊断方法和风险分层
J Clin Med. 2025 Mar 16;14(6):2014. doi: 10.3390/jcm14062014.
5
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.轻链型和转甲状腺素蛋白淀粉样变临床试验影像终点的发展：淀粉样变论坛会议记录
JACC Cardiovasc Imaging. 2025 May;18(5):602-617. doi: 10.1016/j.jcmg.2024.11.003. Epub 2025 Feb 21.
6
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis.心脏淀粉样变性患者心电图表现的进展及预后意义
ESC Heart Fail. 2025 Apr;12(2):809-818. doi: 10.1002/ehf2.14684. Epub 2024 Dec 12.
7
Novel Insights into Non-Invasive Diagnostic Techniques for Cardiac Amyloidosis: A Critical Review.心脏淀粉样变性无创诊断技术的新见解：一项批判性综述。
Diagnostics (Basel). 2024 Oct 9;14(19):2249. doi: 10.3390/diagnostics14192249.
8
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis.系统性轻链淀粉样变的心肌特征、心脏结构和心功能。
JACC Cardiovasc Imaging. 2024 Nov;17(11):1271-1286. doi: 10.1016/j.jcmg.2024.05.004. Epub 2024 Jul 10.
9
The Role of T2 Mapping in Cardiac Amyloidosis.T2 映射在心脏淀粉样变性中的作用
Diagnostics (Basel). 2024 May 18;14(10):1048. doi: 10.3390/diagnostics14101048.
10
Light-Chain Cardiac Amyloidosis: Cardiac Magnetic Resonance for Assessing Response to Chemotherapy.轻链心脏淀粉样变：评估化疗反应的心脏磁共振成像。
Korean J Radiol. 2024 May;25(5):426-437. doi: 10.3348/kjr.2023.0985.